AIZ vs GLUE · P/E 15, rev $3.45B vs rev $123.7M
Assurant Inc (AIZ) versus Monte Rosa Therapeutics Inc (GLUE) — a side-by-side from cached financials, not a winner call.
Assurant Inc (AIZ) is a insurance - property & casualty company listed on US.
Monte Rosa Therapeutics Inc (GLUE) is a biotechnology company listed on NASDAQ.
Latest reported AIZ revenue for 2026-06-30 was $3.45B. Net income was $298.6M. Revenue was up 1.0% from 2026-03-31 to 2026-06-30. AIZ currently screens at market cap $9.98B and trailing P/E 15.4.
Latest reported GLUE revenue for 2025-12-31 was $123.7M. Net income was -$38.6M. GLUE currently screens at market cap $1.56B.
AIZ currently screens at market cap $9.98B and trailing P/E 15.4. GLUE currently screens at market cap $1.56B.
Not investment advice. Open the AIZ and GLUE stock pages for the full models.
Not investment advice.